EGFR and neoplasm: Static magnetic field therapy operates through multiple mechanisms, including interference with oncogenic signaling pathways (such as EGFR), alteration of ionic environments and the cytoskeleton, and enhancing the tumor cells’ sensitivity to other treatments, all while avoiding additional toxicity.